SCHEMBL10240564

SCHEMBL10240564

O=S(=O)(Nc1cccc2c1CCNC2)c1ccc2c(c1)OCCO2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.54
KDM4E B2RXH2 4/20 0.52
HPGD P15428 3/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
IDO1 P14902 1/20 0.51
MAPT P10636 3/20 0.50
L3MBTL1 Q9Y468 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
GAA P10253 2/20 0.49
LMNA P02545 2/20 0.49
HTT P42858 1/20 0.49
HSD17B10 Q99714 3/20 0.48
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
SPR P35270 1/20 0.46
FFAR4 Q5NUL3 1/20 0.46
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
GLO1 Q04760 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9958439 0.99 ALDH1A1 (0.53) ALDH1A1KDM4EHPGDCYP2C9CYP2C19
SCHEMBL10239981 0.84 PTGES2 (0.60) ALDH1A1L3MBTL1GAALMNAHTT
Hydrochloric Acid SCHEMBL9958693 0.83 PTGES2 (0.59) ALDH1A1GAALMNAHTTTSHR
SCHEMBL10239990 0.81 MEN1 (0.50) ALDH1A1KDM4EGAALMNAHTT
Hydrochloric Acid SCHEMBL9960378 0.80 MEN1 (0.49) ALDH1A1KDM4EGAALMNAHTT
SCHEMBL10240493 0.79 PKM (0.54) ALDH1A1KDM4ECYP2C9CYP2C19SMN1; SMN2
Hydrochloric Acid SCHEMBL9958322 0.79 PKM (0.53) ALDH1A1KDM4ECYP2C9CYP2C19SMN1; SMN2
Hydrochloric Acid SCHEMBL10356561 0.78 HTR6 (0.56) ALDH1A1KDM4EMAPTSMN1; SMN2GAA
SCHEMBL10239996 0.78 HTR6 (0.49) ALDH1A1HPGDMAPTGAALMNA
SCHEMBL13757810 0.77 PNMT (0.62) ALDH1A1HPGDMAPTSMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2007729-B1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS ESTEVE LABOR DR (ES) 2012-06-27 EP disclosed
US-20090209528-A1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUND, THEIR PREPARATION AND USE IN MEDICAMENTS LABORATORIOS DEL DR. ESTEVE S.A. (ES) 2009-08-20 US disclosed
US-20090209528-A1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUND, THEIR PREPARATION AND USE IN MEDICAMENTS LABORATORIOS DEL DR. ESTEVE S.A. (ES) 2009-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209528-A1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUND, THEIR PREPARATION AND USE IN MEDICAMENTS HTR6, HTR5A, HTR7 ALDH1A1 1731/4885KDM4E 3367/4885HPGD 465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.